Atay, D. Et Al. 2015. Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.7 , 543-547.

Atay, D., Erbey, F., Akcay, A., Dag, A., & Ozturk, G., (2015). Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.7, 543-547.

Atay, DİDEM Et Al. "Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients," JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.7, 543-547, 2015

Atay, DİDEM Et Al. "Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients." JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.7, pp.543-547, 2015

Atay, D. Et Al. (2015) . "Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients." JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.7, pp.543-547.

@article{article, author={DİDEM ATAY Et Al. }, title={Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients}, journal={JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY}, year=2015, pages={543-547} }